Nyrada Inc. (ASX:NYR)
Australia · Delayed Price · Currency is AUD 0.7200
+0.0350 (5.11%)
Sep 10, 2026, 4:10 PM AEST
Nyrada Market Cap
Nyrada has a market cap or net worth of 177.91 million as of September 10, 2026. Its market cap has increased by 161.30% in one year.
Market Cap
177.91M
Enterprise Value
169.52M
Revenue
2.01M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.72
ChartMarket Cap Chart
Since January 16, 2020, Nyrada's market cap has increased from 25.71M to 177.91M, an increase of 592.11%. That is a compound annual growth rate of 33.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 177.91M | -34.70% |
| Dec 31, 2025 | 272.45M | 1,278.00% |
| Dec 31, 2024 | 19.77M | 476.06% |
| Dec 29, 2023 | 3.43M | -84.83% |
| Dec 30, 2022 | 22.62M | -39.58% |
| Dec 31, 2021 | 37.44M | 42.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Starpharma Holdings | 386.25M |
| Tetratherix | 380.80M |
| BLS Pharmaceuticals | 260.24M |
| Actinogen Medical | 234.32M |
| Orthocell | 198.80M |
| Paradigm Biopharmaceuticals | 164.78M |
| Dimerix | 162.11M |
| Island Pharmaceuticals | 130.20M |